These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23591197)

  • 41. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cells.
    Palve VC; Teni TR
    Radiat Oncol; 2012 Aug; 7():135. PubMed ID: 22873792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
    Tseng HH; Tseng YK; You JJ; Kang BH; Wang TH; Yang CM; Chen HC; Liou HH; Liu PF; Ger LP; Tsai KW
    Anticancer Res; 2017 Mar; 37(3):1059-1066. PubMed ID: 28314265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
    Chi H
    Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers.
    Huang J; Meng Q; Liu R; Li H; Li Y; Yang Z; Wang Y; Wanyan C; Yang X; Wei J
    Clin Transl Oncol; 2023 Oct; 25(10):3006-3020. PubMed ID: 37029240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LncRNA DANCR regulates the growth and metastasis of oral squamous cell carcinoma cells via altering miR-216a-5p expression.
    Qu XH; Shi YL; Ma Y; Bao WW; Yang L; Li JC; Zhang F
    Hum Cell; 2020 Oct; 33(4):1281-1293. PubMed ID: 32860589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells.
    Ishigami T; Uzawa K; Higo M; Nomura H; Saito K; Kato Y; Nakashima D; Shiiba M; Bukawa H; Yokoe H; Kawata T; Ito H; Tanzawa H
    Int J Cancer; 2007 May; 120(10):2262-70. PubMed ID: 17290400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioinformatics analysis of dysregulated exosomal microRNAs derived from oral squamous cell carcinoma cells.
    Masaoka T; Shinozuka K; Ohara K; Tsuda H; Imai K; Tonogi M
    J Oral Sci; 2021 Mar; 63(2):174-178. PubMed ID: 33731508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.
    Lin SC; Liu CJ; Lin JA; Chiang WF; Hung PS; Chang KW
    Oral Oncol; 2010 Mar; 46(3):204-8. PubMed ID: 20138800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-935 Inhibits Oral Squamous Cell Carcinoma and Targets Inositol Polyphosphate-4-phosphatase Type IA (INPP4A).
    Maruyama N; Umikawa M; Matsumoto H; Maruyama T; Nishihara K; Nakasone T; Matayoshi A; Goto T; Hirano F; Arasaki A; Nakamura H; Matsuzaki G; Takaesu G
    Anticancer Res; 2020 Nov; 40(11):6101-6113. PubMed ID: 33109548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Expression and clinical significance of plasma microRNA-125b level in patients with oral squamous cell carcinoma].
    Gu WL; Ye DX; Wu JJ
    Shanghai Kou Qiang Yi Xue; 2015 Feb; 24(1):71-5. PubMed ID: 25858373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
    Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
    Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alkannin restrains oral squamous carcinoma cell growth, migration and invasion by regulating microRNA-9/RECK axis.
    Mao Y; Zhang W; Zhang R; Zuo J
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3153-3162. PubMed ID: 31349748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-205-5p suppresses the invasiveness of oral squamous cell carcinoma by inhibiting TIMP‑2 expression.
    Nagai H; Hasegawa S; Uchida F; Terabe T; Ishibashi Kanno N; Kato K; Yamagata K; Sakai S; Kawashiri S; Sato H; Yanagawa T; Bukawa H
    Int J Oncol; 2018 Mar; 52(3):841-850. PubMed ID: 29393341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-22 suppresses cell proliferation, migration and invasion in oral squamous cell carcinoma by targeting NLRP3.
    Feng X; Luo Q; Wang H; Zhang H; Chen F
    J Cell Physiol; 2018 Sep; 233(9):6705-6713. PubMed ID: 29319163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-92b promotes tumor growth and activation of NF-κB signaling via regulation of NLK in oral squamous cell carcinoma.
    Liu Z; Diep C; Mao T; Huang L; Merrill R; Zhang Z; Peng Y
    Oncol Rep; 2015 Dec; 34(6):2961-8. PubMed ID: 26503628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2.
    Zeng Q; Tao X; Huang F; Wu T; Wang J; Jiang X; Kuang Z; Cheng B
    Int J Mol Med; 2016 May; 37(5):1274-80. PubMed ID: 26986233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of circular RNA hsa_circ_0008898 on oral squamous cell carcinoma and its mechanism].
    Zhou HX; Wang LY; Chen S; Wang DD; Fang Z
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Aug; 55(8):578-585. PubMed ID: 32842350
    [No Abstract]   [Full Text] [Related]  

  • 59. MiR-223 promotes oral squamous cell carcinoma proliferation and migration by regulating FBXW7.
    Jiang L; Lv L; Liu X; Jiang X; Yin Q; Hao Y; Xiao L
    Cancer Biomark; 2019; 24(3):325-334. PubMed ID: 30883339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
    Xu L; Hou TJ; Yang P
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.